SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001193125-13-350361
Filing Date
2013-08-28
Accepted
2013-08-28 16:21:15
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM F-3 d590098df3.htm F-3 339202
2 EX-5.1 d590098dex51.htm EX-5.1 30082
3 EX-23.1 d590098dex231.htm EX-23.1 1411
4 EX-23.2 d590098dex232.htm EX-23.2 4610
5 GRAPHIC g590098g03r10.jpg GRAPHIC 21611
6 GRAPHIC g590098g12t12.jpg GRAPHIC 24624
7 GRAPHIC g590098g13n37.jpg GRAPHIC 13671
8 GRAPHIC g590098g28i23.jpg GRAPHIC 19649
9 GRAPHIC g590098g63m88.jpg GRAPHIC 12061
10 GRAPHIC g590098g95n51.jpg GRAPHIC 10566
  Complete submission text file 0001193125-13-350361.txt   517905
Mailing Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000
Business Address LEVEL 7, 151 MACQUARIE STREET SYDNEY, NEW SOUTH WALES C3 2000 612 9276 1224
Prima BioMed Ltd (Filer) CIK: 0001506184 (see all company filings)

IRS No.: 000000000
Type: F-3 | Act: 33 | File No.: 333-190864 | Film No.: 131066179
SIC: 2834 Pharmaceutical Preparations